Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market Analysis, Segments, Leading Player, Application & Forecast to 2026

Market and Industry Analytics

Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market Analysis, Segments, Leading Player, Application & Forecast to 2026

Press Release

Platelet-rich plasma (PRP) is a blood product having autologous property. It has a large number of platelets in a very minute quantity of plasma. The platelets which are 2 mm diameter in size are the cytoplasmic fragments of megakaryocytes developed in the marrow. More than 30 bioactive proteins are present in the platelets. These bioactive proteins are equipped with a vital role in tissue healing or hemostasis. Platelet-rich plasma have three main proteins – fibrin, fibronectin, and vitronectin in blood which have an important role in cell adhesion molecules.

View Report-

Differential centrifugation is a process used for the preparation of platelet-rich plasma. Acceleration force in differential centrifugation is used to centrifuge the constituents present in the blood to settle on different specific gravity. Centrifugation is acquired at different relative centrifugal time, force, and temperature. The two-step procedure yields the highest result.

Platelet-rich plasma functions as a fibrin tissue adhesive for hemostatic and tissue covering effects. It is not similar to fibrin glue or platelet-poor tissue adhesives as the platelets have an ability to heal wounds and nourish osteogenesis. Biological isolation of platelet-rich plasma from whole blood is obtained for enriched platelets. Tissue regeneration, inflammatory response, promotion of angiogenesis, and infection controlling are improved with the help of high concentration of platelets in plasma.

Request Brochure-

Acceleration of endothelial, epithelial, and epidermal regeneration, stimulation angiogenesis, development collagen synthesis, promotion of soft tissue healing, reduction of dermal scarring, development of hemostatic response to injuries, and adverse inhibition of wound healing caused by glucocorticoids are all processed by platelet-rich plasma. The higher the leukocyte concentration in platelet-rich plasma, the higher the antimicrobial effect. Platelet-rich plasma does not carry any risk of transmitting infectious disease.

Concentrated bone marrow aspirate (BMA) is obtained from a patient’s own bone marrow. Mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) are very high in concentrated bone marrow aspirate. Bone marrow aspiration concentrate (BMAC) has a great effect on osseous and cartilage defect healing as it contains stem cells and multiple growth factors. Mesenchymal stem cells and bone marrow aspirates concentrates from bone marrow are used in development of rotator cuff tears and for the repair of damaged structures in clinical and preclinical studies as they are a good cell source. However, absence of these factors in sufficient amount may lead to rotator cuff tears.

Request for TOC containing Tables and Figures:

Presence of these concentrates in adequate amount is important in stem cell-mediated repair of tears, including rotator cuff tears. Marrow is an abundant source of “pluripotent” stem cells. It is extracted from the patient’s pelvis and processed. When an injury takes place, a number of regenerative cells are required for tissue regeneration. If regenerative cells are inadequate in the body due to blood loss or any other reason, it might hamper the process. Stem cells are undifferentiated; they replicate themselves as different types of tissues as needed. The concentrate of regenerative cells in bone marrow concentrate provides strong and healthy healing of the damaged tissue, allowing it to grow and repair by exceeding the body’s natural healing process. Bone marrow concentrate also relieves pain, reduces swelling, and boosts healing of articular cartilage and bone.

Bone marrow aspirate concentrate is a cost-effective method in delivering mesenchymal stem cells, helping in the repair and regeneration of cartilage defects. This is expected to drive the growth of the platelet-rich plasma and bone marrow aspirate concentrate systems market during the forecast period. Platelet-rich plasma provides immediate surgical hemostatic agent which is safe, biocompatible, and effective. The strong differences in platelet and growth factor concentrations among other blood products might affect the cell viability or gene expression. Platelet-rich plasma from male and female donors is expected to have significant differences in growth factor content between male and female platelet-rich plasma. This is anticipated to restrain the growth of the platelet-rich plasma and bone marrow aspirate concentrate systems market in the near future.